Saad Mark E 4
4 · Axsome Therapeutics, Inc. · Filed Feb 25, 2025
Insider Transaction Report
Form 4
Saad Mark E
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-21+1,494→ 1,494 totalExercise: $137.75From: 2025-02-21Exp: 2035-02-20→ Common Stock (1,494 underlying)
Footnotes (1)
- [F1]Represents 1,494 options elected to be received in lieu of cash compensation earned in 2024. All of such options are immediately exercisable.